Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 101 articles:
HTML format



Single Articles


    June 2022
  1. NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
    The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
    J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
    PubMed     Abstract available


  2. LOUIE AY, Tingling J, Dray E, Hussain J, et al
    Dietary Cholesterol Causes Inflammatory Imbalance and Exacerbates Morbidity in Mice Infected with Influenza A Virus.
    J Immunol. 2022;208:2523-2539.
    PubMed     Abstract available


  3. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    PubMed     Abstract available


    May 2022
  4. TAN HX, Wragg KM, Kelly HG, Esterbauer R, et al
    Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil.
    J Immunol. 2022;208:2267-2271.
    PubMed     Abstract available


  5. LI H, Zhao M, Zhang H, Quan C, et al
    Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection.
    J Immunol. 2022;208:2154-2162.
    PubMed     Abstract available


    April 2022
  6. HOUSER CL, Lawrence BP
    The Aryl Hydrocarbon Receptor Modulates T Follicular Helper Cell Responses to Influenza Virus Infection in Mice.
    J Immunol. 2022 Apr 20. pii: jimmunol.2100936. doi: 10.4049/jimmunol.2100936.
    PubMed     Abstract available


  7. GOMEZ-LOPEZ N, Romero R, Tao L, Gershater M, et al
    Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women.
    J Immunol. 2022;208:1857-1872.
    PubMed     Abstract available


  8. YANG X, Rutkovsky AC, Zhou J, Zhong Y, et al
    Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
    J Immunol. 2022;208:1968-1977.
    PubMed     Abstract available


  9. ZHAI B, Clarke K, Bauer DL, Moehling Geffel KK, et al
    SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients.
    J Immunol. 2022;208:1711-1718.
    PubMed     Abstract available


    March 2022
  10. JEONG S, Jeon M, Lee H, Kim SY, et al
    IFITM3 Is Upregulated Characteristically in IL-15-Mediated Bystander-Activated CD8(+) T Cells during Influenza Infection.
    J Immunol. 2022 Mar 28. pii: jimmunol.2100629. doi: 10.4049/jimmunol.2100629.
    PubMed     Abstract available


  11. DHUME K, Finn CM, Devarajan P, Singh A, et al
    Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
    J Immunol. 2022 Mar 25. pii: jimmunol.2100801. doi: 10.4049/jimmunol.2100801.
    PubMed     Abstract available


  12. COSTANTINI VP, Nguyen K, Lyski Z, Novosad S, et al
    Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG.
    J Immunol. 2022;208:1500-1508.
    PubMed     Abstract available


  13. HAZAN G, Eubanks A, Gierasch C, Atkinson J, et al
    Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses.
    J Immunol. 2022;208:1467-1482.
    PubMed     Abstract available


  14. GAO X, Zhu B, Wu Y, Li C, et al
    TFAM-Dependent Mitochondrial Metabolism Is Required for Alveolar Macrophage Maintenance and Homeostasis.
    J Immunol. 2022;208:1456-1466.
    PubMed     Abstract available


  15. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    PubMed     Abstract available


    February 2022
  16. MEYER-ARNDT L, Schwarz T, Loyal L, Henze L, et al
    Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4(+) T Cells following BNT162b2 Vaccination in the Elderly.
    J Immunol. 2022 Feb 4. pii: jimmunol.2100990. doi: 10.4049/jimmunol.2100990.
    PubMed     Abstract available


  17. NICOLI F, Cabral-Piccin MP, Papagno L, Gallerani E, et al
    Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8(+) T Cells in Elderly Humans.
    J Immunol. 2022;208:562-570.
    PubMed     Abstract available


  18. SUI C, Xiao T, Zhang S, Zeng H, et al
    SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy.
    J Immunol. 2022;208:753-761.
    PubMed     Abstract available


  19. DUTT TS, LaVergne SM, Webb TL, Baxter BA, et al
    Comprehensive Immune Profiling Reveals CD56(+) Monocytes and CD31(+) Endothelial Cells Are Increased in Severe COVID-19 Disease.
    J Immunol. 2022;208:685-696.
    PubMed     Abstract available


    January 2022
  20. KOMISSAROV AA, Dolzhikova IV, Efimov GA, Logunov DY, et al
    Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
    J Immunol. 2022 Jan 31. pii: jimmunol.2101052. doi: 10.4049/jimmunol.2101052.
    PubMed     Abstract available


  21. TU MK, Chiang SH, Bender RA, Wong DTW, et al
    The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100919. doi: 10.4049/jimmunol.2100919.
    PubMed     Abstract available


  22. LAW JC, Girard M, Chao GYC, Ward LA, et al
    Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.
    J Immunol. 2022;208:429-443.
    PubMed     Abstract available


  23. HOPE JL, Zhao M, Stairiker CJ, Kiernan CH, et al
    MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8(+) T Cell Responses.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000621. doi: 10.4049/jimmunol.2000621.
    PubMed     Abstract available


  24. HARTWIG SM, Miller AM, Varga SM
    Respiratory Syncytial Virus Provides Protection against a Subsequent Influenza A Virus Infection.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000751. doi: 10.4049/jimmunol.2000751.
    PubMed     Abstract available


  25. WU B, Ramaiah A, Garcia G Jr, Hasiakos S, et al
    ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
    J Immunol. 2022;208:74-84.
    PubMed     Abstract available


    November 2021
  26. LIU Y, Budylowski P, Dong S, Li Z, et al
    SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals.
    J Immunol. 2021;207:2581-2588.
    PubMed     Abstract available


  27. HUSSAIN SA, Rohlfing M, Resiliac J, Santoro J, et al
    Atopic Neutrophils Prevent Postviral Airway Disease.
    J Immunol. 2021;207:2589-2597.
    PubMed     Abstract available


  28. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    PubMed     Abstract available


  29. GAJANAYAKA N, Dong SXM, Ali H, Iqbal S, et al
    TLR-4 Agonist Induces IFN-gamma Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.
    J Immunol. 2021;207:2310-2324.
    PubMed     Abstract available


    October 2021
  30. WANG Y, Karki R, Zheng M, Kancharana B, et al
    Cutting Edge: Caspase-8 Is a Linchpin in Caspase-3 and Gasdermin D Activation to Control Cell Death, Cytokine Release, and Host Defense during Influenza A Virus Infection.
    J Immunol. 2021 Oct 18. pii: jimmunol.2100757. doi: 10.4049/jimmunol.2100757.
    PubMed     Abstract available


  31. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    PubMed     Abstract available


  32. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    PubMed     Abstract available


  33. YANG Q, Wen Y, Qi F, Gao X, et al
    Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
    J Immunol. 2021;207:1848-1856.
    PubMed     Abstract available


  34. SCOTT J, Ruchaud-Sparagano MH, Musgrave K, Roy AI, et al
    Phosphoinositide 3-Kinase delta Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection.
    J Immunol. 2021;207:1776-1784.
    PubMed     Abstract available


    September 2021
  35. ALVES I, Vicente MM, Gaifem J, Fernandes A, et al
    SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
    J Immunol. 2021;207:1591-1598.
    PubMed     Abstract available



  36. Top Reads.
    J Immunol. 2021;207:1495.
    PubMed    


  37. MA T, Ryu H, McGregor M, Babcock B, et al
    Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.
    J Immunol. 2021;207:1344-1356.
    PubMed     Abstract available


    August 2021
  38. SHAHBAZ S, Xu L, Sligl W, Osman M, et al
    The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
    J Immunol. 2021;207:1099-1111.
    PubMed     Abstract available


  39. OCHSNER SP, Li W, Rajendrakumar AM, Palaniyandi S, et al
    FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100297. doi: 10.4049/jimmunol.2100297.
    PubMed     Abstract available


  40. VERMA AK, Bauer C, Palani S, Metzger DW, et al
    IFN-gamma Drives TNF-alpha Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Staphylococcus aureus Pneumonia.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100328. doi: 10.4049/jimmunol.2100328.
    PubMed     Abstract available


  41. REYNOLDS D, Vazquez Guillamet C, Day A, Borcherding N, et al
    Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    J Immunol. 2021 Aug 4. pii: jimmunol.2100294. doi: 10.4049/jimmunol.2100294.
    PubMed     Abstract available


  42. BAYARRI-OLMOS R, Idorn M, Rosbjerg A, Perez-Alos L, et al
    SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
    J Immunol. 2021;207:878-887.
    PubMed     Abstract available


    July 2021
  43. AVENDANO-ORTIZ J, Lozano-Rodriguez R, Martin-Quiros A, Maroun-Eid C, et al
    SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.
    J Immunol. 2021;207:162-174.
    PubMed     Abstract available



  44. Top Reads.
    J Immunol. 2021;207:1-2.
    PubMed    


    June 2021
  45. MATCHETT WE, Joag V, Stolley JM, Shepherd FK, et al
    Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.
    J Immunol. 2021 Jun 30. pii: jimmunol.2100421. doi: 10.4049/jimmunol.2100421.
    PubMed     Abstract available


  46. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Correction: Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2021 Jun 18. pii: jimmunol.2100261. doi: 10.4049/jimmunol.2100261.
    PubMed    


  47. LIU X, Zhao J, Wang H, Wang W, et al
    Metabolic Defects of Peripheral T Cells in COVID-19 Patients.
    J Immunol. 2021;206:2900-2908.
    PubMed     Abstract available



  48. Top Reads.
    J Immunol. 2021;206:2773-2774.
    PubMed    


  49. HOEHN KB, Ramanathan P, Unterman A, Sumida TS, et al
    Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.
    J Immunol. 2021;206:2785-2790.
    PubMed     Abstract available


  50. SANDOR AM, Sturdivant MS, Ting JPY
    Influenza Virus and SARS-CoV-2 Vaccines.
    J Immunol. 2021;206:2509-2520.
    PubMed     Abstract available


  51. JAHRSDORFER B, Gross R, Seidel A, Wettstein L, et al
    Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
    J Immunol. 2021;206:2614-2622.
    PubMed     Abstract available


  52. MANTUS G, Nyhoff LE, Kauffman RC, Edara VV, et al
    Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.
    J Immunol. 2021;206:2605-2613.
    PubMed     Abstract available


    May 2021
  53. OCCHIGROSSI L, Rossin F, D'Eletto M, Farrace MG, et al
    Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
    J Immunol. 2021;206:2420-2429.
    PubMed     Abstract available


  54. FUJIGAKI H, Inaba M, Osawa M, Moriyama S, et al
    Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.
    J Immunol. 2021;206:2393-2401.
    PubMed     Abstract available


  55. YAN Q, Li P, Ye X, Huang X, et al
    Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
    J Immunol. 2021;206:2146-2159.
    PubMed     Abstract available


    April 2021
  56. CROOKE PS 3RD, Tossberg JT, Porter KP, Aune TM, et al
    Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
    J Immunol. 2021;206:1691-1696.
    PubMed     Abstract available


  57. HUANG W, Li M, Luo G, Wu X, et al
    The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.
    J Immunol. 2021;206:1597-1608.
    PubMed     Abstract available


  58. RUPP J, Dreo B, Gutl K, Fessler J, et al
    T Cell Phenotyping in Individuals Hospitalized with COVID-19.
    J Immunol. 2021;206:1478-1482.
    PubMed     Abstract available


  59. FRANZETTI M, Forastieri A, Borsa N, Pandolfo A, et al
    IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
    J Immunol. 2021;206:1569-1575.
    PubMed     Abstract available


  60. PRICE MJ, Scharer CD, Kania AK, Randall TD, et al
    Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation.
    J Immunol. 2021;206:1493-1504.
    PubMed     Abstract available


    March 2021
  61. MALINCZAK CA, Parolia A, Fonseca W, Morris S, et al
    TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
    J Immunol. 2021;206:1315-1328.
    PubMed     Abstract available


    February 2021
  62. TIAN J, Zhang M, Jin M, Zhang F, et al
    Repurposed Tocilizumab in Patients with Severe COVID-19.
    J Immunol. 2021;206:599-606.
    PubMed     Abstract available


  63. ZELBA H, Worbs D, Harter J, Pieper N, et al
    A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.
    J Immunol. 2021;206:580-587.
    PubMed     Abstract available


    January 2021
  64. SCHWARZ B, Sharma L, Roberts L, Peng X, et al
    Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
    J Immunol. 2021;206:329-334.
    PubMed     Abstract available


  65. JOAG V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, et al
    Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
    J Immunol. 2021 Jan 13. pii: jimmunol.2001400. doi: 10.4049/jimmunol.2001400.
    PubMed     Abstract available


  66. HANSEN CB, Jarlhelt I, Perez-Alos L, Hummelshoj Landsy L, et al
    SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
    J Immunol. 2021;206:109-117.
    PubMed     Abstract available


    December 2020
  67. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2020 Dec 16. pii: jimmunol.2001086. doi: 10.4049/jimmunol.2001086.
    PubMed     Abstract available


  68. VOGELZANG EH, Loeff FC, Derksen NIL, Kruithof S, et al
    Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
    J Immunol. 2020;205:3491-3499.
    PubMed     Abstract available


  69. MARTINEZ-FLETA P, Alfranca A, Gonzalez-Alvaro I, Casasnovas JM, et al
    SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
    J Immunol. 2020;205:3130-3140.
    PubMed     Abstract available


  70. KELLAR GG, Reeves SR, Barrow KA, Debley JS, et al
    Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
    J Immunol. 2020;205:3050-3057.
    PubMed     Abstract available


    November 2020
  71. LAW JC, Koh WH, Budylowski P, Lin J, et al
    Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
    J Immunol. 2020 Nov 18. pii: jimmunol.2001067. doi: 10.4049/jimmunol.2001067.
    PubMed     Abstract available


  72. KALKAN YAZICI M, Koc MM, Cetin NS, Karaaslan E, et al
    Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
    J Immunol. 2020;205:2719-2725.
    PubMed     Abstract available


  73. NOWILL AE, de Campos-Lima PO
    Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    J Immunol. 2020;205:2566-2575.
    PubMed     Abstract available


  74. BAUMGARTH N, Nikolich-Zugich J, Lee FE, Bhattacharya D, et al
    Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
    J Immunol. 2020;205:2342-2350.
    PubMed     Abstract available


  75. VARNAITE R, Garcia M, Glans H, Maleki KT, et al
    Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    J Immunol. 2020;205:2437-2446.
    PubMed     Abstract available


    October 2020
  76. ELAHI S
    Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
    J Immunol. 2020;205:1990-1997.
    PubMed     Abstract available


    September 2020
  77. SOKULSKY LA, Garcia-Netto K, Nguyen TH, Girkin JLN, et al
    A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation.
    J Immunol. 2020 Sep 18. pii: jimmunol.1901350. doi: 10.4049/jimmunol.1901350.
    PubMed     Abstract available


  78. WONG LR, Ye ZW, Lui PY, Zheng X, et al
    Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKepsilon.
    J Immunol. 2020;205:1564-1579.
    PubMed     Abstract available


  79. LO MW, Kemper C, Woodruff TM
    COVID-19: Complement, Coagulation, and Collateral Damage.
    J Immunol. 2020;205:1488-1495.
    PubMed     Abstract available


  80. XIA J, Kuang Y, Liang J, Jones M, et al
    Influenza Vaccine-Induced CD4 Effectors Require Antigen Recognition at an Effector Checkpoint to Generate CD4 Lung Memory and Antibody Production.
    J Immunol. 2020 Sep 14. pii: jimmunol.2000597. doi: 10.4049/jimmunol.2000597.
    PubMed     Abstract available


  81. FRANCO R, Rivas-Santisteban R, Serrano-Marin J, Rodriguez-Perez AI, et al
    SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
    J Immunol. 2020;205:1198-1206.
    PubMed     Abstract available


    August 2020
  82. ASSMUS LM, Guan J, Wu T, Farenc C, et al
    Overlapping Peptides Elicit Distinct CD8(+) T Cell Responses following Influenza A Virus Infection.
    J Immunol. 2020 Aug 31. pii: jimmunol.2000689. doi: 10.4049/jimmunol.2000689.
    PubMed     Abstract available


  83. ORLOV M, Wander PL, Morrell ED, Mikacenic C, et al
    A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.
    J Immunol. 2020;205:892-898.
    PubMed     Abstract available


  84. ALSOUSSI WB, Turner JS, Case JB, Zhao H, et al
    A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
    J Immunol. 2020;205:915-922.
    PubMed     Abstract available


  85. VERMA AK, Bansal S, Bauer C, Muralidharan A, et al
    Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive Streptococcus pneumoniae to Cause Deadly Pneumonia.
    J Immunol. 2020 Aug 12. pii: jimmunol.2000094. doi: 10.4049/jimmunol.2000094.
    PubMed     Abstract available


  86. ST JOHN AL, Rathore APS
    Early Insights into Immune Responses during COVID-19.
    J Immunol. 2020;205:555-564.
    PubMed     Abstract available


    July 2020
  87. YAP JKY, Moriyama M, Iwasaki A
    Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.
    J Immunol. 2020;205:307-312.
    PubMed     Abstract available


  88. CHEN J, Kelley WJ, Goldstein DR
    Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
    J Immunol. 2020;205:313-320.
    PubMed     Abstract available


  89. MANJILI RH, Zarei M, Habibi M, Manjili MH, et al
    COVID-19 as an Acute Inflammatory Disease.
    J Immunol. 2020;205:12-19.
    PubMed     Abstract available


    June 2020
  90. MCNEE A, Smith TRF, Holzer B, Clark B, et al
    Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms.
    J Immunol. 2020 Jun 26. pii: jimmunol.2000429. doi: 10.4049/jimmunol.2000429.
    PubMed     Abstract available


  91. CASALINO-MATSUDA SM, Chen F, Gonzalez-Gonzalez FJ, Nair A, et al
    Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1.
    J Immunol. 2020 Jun 15. pii: jimmunol.2000085. doi: 10.4049/jimmunol.2000085.
    PubMed     Abstract available


  92. TOBIN JM, Nickolich KL, Ramanan K, Pilewski MJ, et al
    Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis.
    J Immunol. 2020 Jun 10. pii: jimmunol.2000067. doi: 10.4049/jimmunol.2000067.
    PubMed     Abstract available


    May 2020
  93. ALAM F, Singh A, Flores-Malavet V, Sell S, et al
    CD25-Targeted IL-2 Signals Promote Improved Outcomes of Influenza Infection and Boost Memory CD4 T Cell Formation.
    J Immunol. 2020 May 6. pii: jimmunol.2000205. doi: 10.4049/jimmunol.2000205.
    PubMed     Abstract available


    February 2020
  94. AVEY S, Mohanty S, Chawla DG, Meng H, et al
    Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.
    J Immunol. 2020 Feb 14. pii: jimmunol.1900922. doi: 10.4049/jimmunol.1900922.
    PubMed     Abstract available


    January 2020
  95. BLUNDELL PA, Lu D, Dell A, Haslam S, et al
    Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses.
    J Immunol. 2020 Jan 6. pii: jimmunol.1901145. doi: 10.4049/jimmunol.1901145.
    PubMed     Abstract available


  96. MALINCZAK CA, Rasky AJ, Fonseca W, Schaller MA, et al
    Upregulation of H3K27 Demethylase KDM6 During Respiratory Syncytial Virus Infection Enhances Proinflammatory Responses and Immunopathology.
    J Immunol. 2020;204:159-168.
    PubMed     Abstract available


    December 2019
  97. SAUTTO GA, Kirchenbaum GA, Abreu RB, Ecker JW, et al
    A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
    J Immunol. 2019 Dec 6. pii: jimmunol.1900379. doi: 10.4049/jimmunol.1900379.
    PubMed     Abstract available


    November 2019
  98. ZACHARIAS ZR, Legge KL
    Chronic Ethanol Consumption Reduces Existing CD8 T Cell Memory and Is Associated with Lesions in Protection against Secondary Influenza A Virus Infections.
    J Immunol. 2019 Nov 11. pii: jimmunol.1900770. doi: 10.4049/jimmunol.1900770.
    PubMed     Abstract available


    April 2019
  99. SCHMIDT ME, Oomens AGP, Varga SM
    Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice.
    J Immunol. 2019 Apr 19. pii: jimmunol.1900050. doi: 10.4049/jimmunol.1900050.
    PubMed     Abstract available


    February 2019
  100. PERCOPO CM, Ma M, Brenner TA, Krumholz JO, et al
    Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.
    J Immunol. 2019;202:871-882.
    PubMed     Abstract available


    January 2019
  101. JAMIESON KC, Traves SL, Kooi C, Wiehler S, et al
    Rhinovirus and Bacteria Synergistically Induce IL-17C Release from Human Airway Epithelial Cells To Promote Neutrophil Recruitment.
    J Immunol. 2019;202:160-170.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: